George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 3,707 shares at $4.38 ($16K) on 2021-06-21, disclosed to the SEC on 2021-06-23.
Scheduled sale ($16k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2022-01-20 | $23K | — | Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |